Medical Care

Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Research Report 2025

The global market for Systemic Aspergillosis and Systemic Candidiasis Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Systemic Aspergillosis and Systemic Candidiasis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Systemic Aspergillosis and Systemic Candidiasis Treatment.
The Systemic Aspergillosis and Systemic Candidiasis Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Systemic Aspergillosis and Systemic Candidiasis Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Systemic Aspergillosis and Systemic Candidiasis Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Basilea Pharmaceutica
Astellas Pharma
Ferrer International
Pacgen Life Science
NovaDigm Therapeutics
Cidara Therapeutics
Amplyx Pharmaceuticals
Pfizer
Novartis
Sanofi
Merck
Bayer
GlaxoSmithKline
Abbott
Cipla
Segment by Type
Voriconazole
Liposomal Amphotericin B
Systemic Oral Azoles
Topical Antifungal Agents
Others
Segment by Application
Chronic Pulmonary Aspergillosis (CPA)
Allergic Bronchopulmonary Aspergillosis (ABPA)
Gastrointestinal Candidiasis
Genitourinary Tract Candidiasis
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Systemic Aspergillosis and Systemic Candidiasis Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Voriconazole
1.2.3 Liposomal Amphotericin B
1.2.4 Systemic Oral Azoles
1.2.5 Topical Antifungal Agents
1.2.6 Others
1.3 Market by Application
1.3.1 Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Chronic Pulmonary Aspergillosis (CPA)
1.3.3 Allergic Bronchopulmonary Aspergillosis (ABPA)
1.3.4 Gastrointestinal Candidiasis
1.3.5 Genitourinary Tract Candidiasis
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Perspective (2020-2031)
2.2 Global Systemic Aspergillosis and Systemic Candidiasis Treatment Growth Trends by Region
2.2.1 Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Systemic Aspergillosis and Systemic Candidiasis Treatment Historic Market Size by Region (2020-2025)
2.2.3 Systemic Aspergillosis and Systemic Candidiasis Treatment Forecasted Market Size by Region (2026-2031)
2.3 Systemic Aspergillosis and Systemic Candidiasis Treatment Market Dynamics
2.3.1 Systemic Aspergillosis and Systemic Candidiasis Treatment Industry Trends
2.3.2 Systemic Aspergillosis and Systemic Candidiasis Treatment Market Drivers
2.3.3 Systemic Aspergillosis and Systemic Candidiasis Treatment Market Challenges
2.3.4 Systemic Aspergillosis and Systemic Candidiasis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Systemic Aspergillosis and Systemic Candidiasis Treatment Players by Revenue
3.1.1 Global Top Systemic Aspergillosis and Systemic Candidiasis Treatment Players by Revenue (2020-2025)
3.1.2 Global Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue
3.4 Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Concentration Ratio
3.4.1 Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue in 2024
3.5 Global Key Players of Systemic Aspergillosis and Systemic Candidiasis Treatment Head office and Area Served
3.6 Global Key Players of Systemic Aspergillosis and Systemic Candidiasis Treatment, Product and Application
3.7 Global Key Players of Systemic Aspergillosis and Systemic Candidiasis Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Systemic Aspergillosis and Systemic Candidiasis Treatment Breakdown Data by Type
4.1 Global Systemic Aspergillosis and Systemic Candidiasis Treatment Historic Market Size by Type (2020-2025)
4.2 Global Systemic Aspergillosis and Systemic Candidiasis Treatment Forecasted Market Size by Type (2026-2031)
5 Systemic Aspergillosis and Systemic Candidiasis Treatment Breakdown Data by Application
5.1 Global Systemic Aspergillosis and Systemic Candidiasis Treatment Historic Market Size by Application (2020-2025)
5.2 Global Systemic Aspergillosis and Systemic Candidiasis Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size (2020-2031)
6.2 North America Systemic Aspergillosis and Systemic Candidiasis Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size by Country (2020-2025)
6.4 North America Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size (2020-2031)
7.2 Europe Systemic Aspergillosis and Systemic Candidiasis Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size by Country (2020-2025)
7.4 Europe Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size (2020-2031)
8.2 Asia-Pacific Systemic Aspergillosis and Systemic Candidiasis Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size (2020-2031)
9.2 Latin America Systemic Aspergillosis and Systemic Candidiasis Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size by Country (2020-2025)
9.4 Latin America Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size (2020-2031)
10.2 Middle East & Africa Systemic Aspergillosis and Systemic Candidiasis Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Basilea Pharmaceutica
11.1.1 Basilea Pharmaceutica Company Details
11.1.2 Basilea Pharmaceutica Business Overview
11.1.3 Basilea Pharmaceutica Systemic Aspergillosis and Systemic Candidiasis Treatment Introduction
11.1.4 Basilea Pharmaceutica Revenue in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025)
11.1.5 Basilea Pharmaceutica Recent Development
11.2 Astellas Pharma
11.2.1 Astellas Pharma Company Details
11.2.2 Astellas Pharma Business Overview
11.2.3 Astellas Pharma Systemic Aspergillosis and Systemic Candidiasis Treatment Introduction
11.2.4 Astellas Pharma Revenue in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025)
11.2.5 Astellas Pharma Recent Development
11.3 Ferrer International
11.3.1 Ferrer International Company Details
11.3.2 Ferrer International Business Overview
11.3.3 Ferrer International Systemic Aspergillosis and Systemic Candidiasis Treatment Introduction
11.3.4 Ferrer International Revenue in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025)
11.3.5 Ferrer International Recent Development
11.4 Pacgen Life Science
11.4.1 Pacgen Life Science Company Details
11.4.2 Pacgen Life Science Business Overview
11.4.3 Pacgen Life Science Systemic Aspergillosis and Systemic Candidiasis Treatment Introduction
11.4.4 Pacgen Life Science Revenue in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025)
11.4.5 Pacgen Life Science Recent Development
11.5 NovaDigm Therapeutics
11.5.1 NovaDigm Therapeutics Company Details
11.5.2 NovaDigm Therapeutics Business Overview
11.5.3 NovaDigm Therapeutics Systemic Aspergillosis and Systemic Candidiasis Treatment Introduction
11.5.4 NovaDigm Therapeutics Revenue in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025)
11.5.5 NovaDigm Therapeutics Recent Development
11.6 Cidara Therapeutics
11.6.1 Cidara Therapeutics Company Details
11.6.2 Cidara Therapeutics Business Overview
11.6.3 Cidara Therapeutics Systemic Aspergillosis and Systemic Candidiasis Treatment Introduction
11.6.4 Cidara Therapeutics Revenue in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025)
11.6.5 Cidara Therapeutics Recent Development
11.7 Amplyx Pharmaceuticals
11.7.1 Amplyx Pharmaceuticals Company Details
11.7.2 Amplyx Pharmaceuticals Business Overview
11.7.3 Amplyx Pharmaceuticals Systemic Aspergillosis and Systemic Candidiasis Treatment Introduction
11.7.4 Amplyx Pharmaceuticals Revenue in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025)
11.7.5 Amplyx Pharmaceuticals Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Details
11.8.2 Pfizer Business Overview
11.8.3 Pfizer Systemic Aspergillosis and Systemic Candidiasis Treatment Introduction
11.8.4 Pfizer Revenue in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025)
11.8.5 Pfizer Recent Development
11.9 Novartis
11.9.1 Novartis Company Details
11.9.2 Novartis Business Overview
11.9.3 Novartis Systemic Aspergillosis and Systemic Candidiasis Treatment Introduction
11.9.4 Novartis Revenue in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025)
11.9.5 Novartis Recent Development
11.10 Sanofi
11.10.1 Sanofi Company Details
11.10.2 Sanofi Business Overview
11.10.3 Sanofi Systemic Aspergillosis and Systemic Candidiasis Treatment Introduction
11.10.4 Sanofi Revenue in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025)
11.10.5 Sanofi Recent Development
11.11 Merck
11.11.1 Merck Company Details
11.11.2 Merck Business Overview
11.11.3 Merck Systemic Aspergillosis and Systemic Candidiasis Treatment Introduction
11.11.4 Merck Revenue in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025)
11.11.5 Merck Recent Development
11.12 Bayer
11.12.1 Bayer Company Details
11.12.2 Bayer Business Overview
11.12.3 Bayer Systemic Aspergillosis and Systemic Candidiasis Treatment Introduction
11.12.4 Bayer Revenue in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025)
11.12.5 Bayer Recent Development
11.13 GlaxoSmithKline
11.13.1 GlaxoSmithKline Company Details
11.13.2 GlaxoSmithKline Business Overview
11.13.3 GlaxoSmithKline Systemic Aspergillosis and Systemic Candidiasis Treatment Introduction
11.13.4 GlaxoSmithKline Revenue in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025)
11.13.5 GlaxoSmithKline Recent Development
11.14 Abbott
11.14.1 Abbott Company Details
11.14.2 Abbott Business Overview
11.14.3 Abbott Systemic Aspergillosis and Systemic Candidiasis Treatment Introduction
11.14.4 Abbott Revenue in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025)
11.14.5 Abbott Recent Development
11.15 Cipla
11.15.1 Cipla Company Details
11.15.2 Cipla Business Overview
11.15.3 Cipla Systemic Aspergillosis and Systemic Candidiasis Treatment Introduction
11.15.4 Cipla Revenue in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025)
11.15.5 Cipla Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Voriconazole
Table 3. Key Players of Liposomal Amphotericin B
Table 4. Key Players of Systemic Oral Azoles
Table 5. Key Players of Topical Antifungal Agents
Table 6. Key Players of Others
Table 7. Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Share by Region (2020-2025)
Table 11. Global Systemic Aspergillosis and Systemic Candidiasis Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Share by Region (2026-2031)
Table 13. Systemic Aspergillosis and Systemic Candidiasis Treatment Market Trends
Table 14. Systemic Aspergillosis and Systemic Candidiasis Treatment Market Drivers
Table 15. Systemic Aspergillosis and Systemic Candidiasis Treatment Market Challenges
Table 16. Systemic Aspergillosis and Systemic Candidiasis Treatment Market Restraints
Table 17. Global Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Share by Players (2020-2025)
Table 19. Global Top Systemic Aspergillosis and Systemic Candidiasis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Systemic Aspergillosis and Systemic Candidiasis Treatment as of 2024)
Table 20. Ranking of Global Top Systemic Aspergillosis and Systemic Candidiasis Treatment Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Systemic Aspergillosis and Systemic Candidiasis Treatment, Headquarters and Area Served
Table 23. Global Key Players of Systemic Aspergillosis and Systemic Candidiasis Treatment, Product and Application
Table 24. Global Key Players of Systemic Aspergillosis and Systemic Candidiasis Treatment, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue Market Share by Type (2020-2025)
Table 28. Global Systemic Aspergillosis and Systemic Candidiasis Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue Market Share by Type (2026-2031)
Table 30. Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue Market Share by Application (2020-2025)
Table 32. Global Systemic Aspergillosis and Systemic Candidiasis Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue Market Share by Application (2026-2031)
Table 34. North America Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 49. Basilea Pharmaceutica Company Details
Table 50. Basilea Pharmaceutica Business Overview
Table 51. Basilea Pharmaceutica Systemic Aspergillosis and Systemic Candidiasis Treatment Product
Table 52. Basilea Pharmaceutica Revenue in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025) & (US$ Million)
Table 53. Basilea Pharmaceutica Recent Development
Table 54. Astellas Pharma Company Details
Table 55. Astellas Pharma Business Overview
Table 56. Astellas Pharma Systemic Aspergillosis and Systemic Candidiasis Treatment Product
Table 57. Astellas Pharma Revenue in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025) & (US$ Million)
Table 58. Astellas Pharma Recent Development
Table 59. Ferrer International Company Details
Table 60. Ferrer International Business Overview
Table 61. Ferrer International Systemic Aspergillosis and Systemic Candidiasis Treatment Product
Table 62. Ferrer International Revenue in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025) & (US$ Million)
Table 63. Ferrer International Recent Development
Table 64. Pacgen Life Science Company Details
Table 65. Pacgen Life Science Business Overview
Table 66. Pacgen Life Science Systemic Aspergillosis and Systemic Candidiasis Treatment Product
Table 67. Pacgen Life Science Revenue in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025) & (US$ Million)
Table 68. Pacgen Life Science Recent Development
Table 69. NovaDigm Therapeutics Company Details
Table 70. NovaDigm Therapeutics Business Overview
Table 71. NovaDigm Therapeutics Systemic Aspergillosis and Systemic Candidiasis Treatment Product
Table 72. NovaDigm Therapeutics Revenue in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025) & (US$ Million)
Table 73. NovaDigm Therapeutics Recent Development
Table 74. Cidara Therapeutics Company Details
Table 75. Cidara Therapeutics Business Overview
Table 76. Cidara Therapeutics Systemic Aspergillosis and Systemic Candidiasis Treatment Product
Table 77. Cidara Therapeutics Revenue in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025) & (US$ Million)
Table 78. Cidara Therapeutics Recent Development
Table 79. Amplyx Pharmaceuticals Company Details
Table 80. Amplyx Pharmaceuticals Business Overview
Table 81. Amplyx Pharmaceuticals Systemic Aspergillosis and Systemic Candidiasis Treatment Product
Table 82. Amplyx Pharmaceuticals Revenue in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025) & (US$ Million)
Table 83. Amplyx Pharmaceuticals Recent Development
Table 84. Pfizer Company Details
Table 85. Pfizer Business Overview
Table 86. Pfizer Systemic Aspergillosis and Systemic Candidiasis Treatment Product
Table 87. Pfizer Revenue in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025) & (US$ Million)
Table 88. Pfizer Recent Development
Table 89. Novartis Company Details
Table 90. Novartis Business Overview
Table 91. Novartis Systemic Aspergillosis and Systemic Candidiasis Treatment Product
Table 92. Novartis Revenue in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025) & (US$ Million)
Table 93. Novartis Recent Development
Table 94. Sanofi Company Details
Table 95. Sanofi Business Overview
Table 96. Sanofi Systemic Aspergillosis and Systemic Candidiasis Treatment Product
Table 97. Sanofi Revenue in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025) & (US$ Million)
Table 98. Sanofi Recent Development
Table 99. Merck Company Details
Table 100. Merck Business Overview
Table 101. Merck Systemic Aspergillosis and Systemic Candidiasis Treatment Product
Table 102. Merck Revenue in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025) & (US$ Million)
Table 103. Merck Recent Development
Table 104. Bayer Company Details
Table 105. Bayer Business Overview
Table 106. Bayer Systemic Aspergillosis and Systemic Candidiasis Treatment Product
Table 107. Bayer Revenue in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025) & (US$ Million)
Table 108. Bayer Recent Development
Table 109. GlaxoSmithKline Company Details
Table 110. GlaxoSmithKline Business Overview
Table 111. GlaxoSmithKline Systemic Aspergillosis and Systemic Candidiasis Treatment Product
Table 112. GlaxoSmithKline Revenue in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025) & (US$ Million)
Table 113. GlaxoSmithKline Recent Development
Table 114. Abbott Company Details
Table 115. Abbott Business Overview
Table 116. Abbott Systemic Aspergillosis and Systemic Candidiasis Treatment Product
Table 117. Abbott Revenue in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025) & (US$ Million)
Table 118. Abbott Recent Development
Table 119. Cipla Company Details
Table 120. Cipla Business Overview
Table 121. Cipla Systemic Aspergillosis and Systemic Candidiasis Treatment Product
Table 122. Cipla Revenue in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025) & (US$ Million)
Table 123. Cipla Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
Table 127. Authors List of This Report


List of Figures
Figure 1. Systemic Aspergillosis and Systemic Candidiasis Treatment Picture
Figure 2. Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Share by Type: 2024 VS 2031
Figure 4. Voriconazole Features
Figure 5. Liposomal Amphotericin B Features
Figure 6. Systemic Oral Azoles Features
Figure 7. Topical Antifungal Agents Features
Figure 8. Others Features
Figure 9. Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Share by Application: 2024 VS 2031
Figure 11. Chronic Pulmonary Aspergillosis (CPA) Case Studies
Figure 12. Allergic Bronchopulmonary Aspergillosis (ABPA) Case Studies
Figure 13. Gastrointestinal Candidiasis Case Studies
Figure 14. Genitourinary Tract Candidiasis Case Studies
Figure 15. Others Case Studies
Figure 16. Systemic Aspergillosis and Systemic Candidiasis Treatment Report Years Considered
Figure 17. Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 18. Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 19. Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Share by Region: 2024 VS 2031
Figure 20. Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Share by Players in 2024
Figure 21. Global Top Systemic Aspergillosis and Systemic Candidiasis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Systemic Aspergillosis and Systemic Candidiasis Treatment as of 2024)
Figure 22. The Top 10 and 5 Players Market Share by Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue in 2024
Figure 23. North America Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. North America Systemic Aspergillosis and Systemic Candidiasis Treatment Market Share by Country (2020-2031)
Figure 25. United States Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Canada Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe Systemic Aspergillosis and Systemic Candidiasis Treatment Market Share by Country (2020-2031)
Figure 29. Germany Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. France Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. U.K. Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Italy Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Russia Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Nordic Countries Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Systemic Aspergillosis and Systemic Candidiasis Treatment Market Share by Region (2020-2031)
Figure 37. China Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Japan Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. South Korea Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. India Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Australia Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America Systemic Aspergillosis and Systemic Candidiasis Treatment Market Share by Country (2020-2031)
Figure 45. Mexico Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Brazil Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa Systemic Aspergillosis and Systemic Candidiasis Treatment Market Share by Country (2020-2031)
Figure 49. Turkey Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. UAE Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Basilea Pharmaceutica Revenue Growth Rate in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025)
Figure 53. Astellas Pharma Revenue Growth Rate in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025)
Figure 54. Ferrer International Revenue Growth Rate in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025)
Figure 55. Pacgen Life Science Revenue Growth Rate in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025)
Figure 56. NovaDigm Therapeutics Revenue Growth Rate in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025)
Figure 57. Cidara Therapeutics Revenue Growth Rate in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025)
Figure 58. Amplyx Pharmaceuticals Revenue Growth Rate in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025)
Figure 59. Pfizer Revenue Growth Rate in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025)
Figure 60. Novartis Revenue Growth Rate in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025)
Figure 61. Sanofi Revenue Growth Rate in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025)
Figure 62. Merck Revenue Growth Rate in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025)
Figure 63. Bayer Revenue Growth Rate in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025)
Figure 64. GlaxoSmithKline Revenue Growth Rate in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025)
Figure 65. Abbott Revenue Growth Rate in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025)
Figure 66. Cipla Revenue Growth Rate in Systemic Aspergillosis and Systemic Candidiasis Treatment Business (2020-2025)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies